Matthew Leming, Ph.D., and Hyungsoon Im, Ph.D. of the Center for Systems Biology at Massachusetts General Hospital, are the ...

A new application that detects signs of pre-dementia in seniors with up to 93 per cent accuracy could be rolled out nationwide next year. Developed by the Singapore General Hospital and GovTech, it ...

This article explores the similarities and differences between nectarines and peaches, including flavor, texture, nutrition, ...

Mild cognitive impairment (MCI) and dementia pose significant health challenges in aging societies, emphasizing the need for accessible, cost-effective, and noninvasive diagnostic tools.

A common painkiller widely prescribed for lower back pain might raise your risk of developing dementia or mild cognitive impairment (MCI). This surprising link was uncovered in new research published ...

The locally developed Pensieve-AI has an accuracy of 93% and can be done in less than 5 minutes. Read more at ...

Researchers discovered that people carrying the APOE ε4 gene variant share a unique immune-related protein signature across ...

The phase 1b PRECISE-AD trial is currently investigating PMN310 in patients with mild cognitive impairment due to AD and in those with mild AD.

Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...

FDA designation highlights the potential of PMN310 to deliver a more targeted approach to treating Alzheimer’s Disease ...

Hollywood icon Bruce Willis’ battle with frontotemporal dementia (FTD) and aphasia has reportedly progressed to the point ...